dihydrostreptomycin sulfate has been researched along with Vertigo in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DUCROT, R; LEAU, O | 1 |
| MEYLER, L | 1 |
| CENZI, P; MEO, G | 1 |
| LINDSAY, JR; PERLMAN, HB | 1 |
| Lerche, S | 1 |
| Falbe-Hansen, J; Rasmussen, F; Worsoe-Petersen, J | 1 |
| Breson, K; Petersen, BN; Rasmussen, F | 1 |
| Gridneva, SM; Koviazina, AI; Stepanian, ES; Utkin, VV | 1 |
1 review(s) available for dihydrostreptomycin sulfate and Vertigo
| Article | Year |
|---|---|
OTONEUROLOGY.
Topics: Craniocerebral Trauma; Deafness; Dihydrostreptomycin Sulfate; Enzymes; Humans; Kanamycin; Meniere Disease; Neurology; Neurotology; Nystagmus, Pathologic; Oculomotor Nerve; Otolaryngology; Reticular Formation; Stapes Surgery; Toxicology; Vertigo; Vestibule, Labyrinth | 1963 |
1 trial(s) available for dihydrostreptomycin sulfate and Vertigo
| Article | Year |
|---|---|
[Test use of dihydrostreptomycin ascorbinate in pulmonary tuberculosis].
Topics: Adult; Ascorbic Acid; Clinical Trials as Topic; Dihydrostreptomycin Sulfate; Drug Eruptions; Eosinophilia; Female; Headache; Humans; Male; Middle Aged; Streptomycin; Sulfates; Tinnitus; Tuberculosis, Pulmonary; Vertigo | 1966 |
6 other study(ies) available for dihydrostreptomycin sulfate and Vertigo
| Article | Year |
|---|---|
[The effect of 2-phenylbutyric acid on ear injuries produced by dihydrostreptomycin in rats and on experimental vertigo in mice].
Topics: Animals; Butyrates; Craniocerebral Trauma; Dihydrostreptomycin Sulfate; Ear Diseases; Ear, Middle; Mice; Phenylbutyrates; Rats; Vertigo | 1958 |
Streptomycin and not dihydrostreptomycin.
Topics: Deafness; Dihydrostreptomycin Sulfate; Hearing Loss; Humans; Streptomycin; Vertigo | 1963 |
[TREATMENT OF OTOTOXIC MANIFESTATIONS DUE TO ANTITUBERCULAR ANTIBIOTIC THERAPY. CLINICAL USE OF A MONOAMINE OXIDASE INHIBITOR (NIALAMIDE)].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Audiometry; Cochlear Nerve; Deafness; Dihydrostreptomycin Sulfate; Kanamycin; Monoamine Oxidase Inhibitors; Nialamide; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Vertigo; Vestibular Nerve; Viomycin | 1964 |
Hearing impairment after prolonged dihydrostreptomycin treatment of surgical tuberculosis.
Topics: Adolescent; Adult; Age Factors; Aged; Audiometry; Body Weight; Child; Dihydrostreptomycin Sulfate; Female; Follow-Up Studies; Hearing Disorders; Humans; Male; Middle Aged; Streptomycin; Time Factors; Tinnitus; Tuberculosis; Vertigo | 1972 |
Ototoxic side effects of the streptomycins, in particular dihydrostreptomycin.
Topics: Adolescent; Adult; Audiometry; Child; Child, Preschool; Dihydrostreptomycin Sulfate; Female; Follow-Up Studies; Hearing Disorders; Hearing Tests; Humans; Infant; Infant, Newborn; Male; Streptomycin; Time Factors; Tuberculosis, Pulmonary; Vertigo | 1972 |
Ototoxicity in 626 patients with pulmonary tuberculosis treated with dihydrostreptomycin, streptomycin sulphate, or a combination of both.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Dihydrostreptomycin Sulfate; Drug Combinations; Female; Follow-Up Studies; Hearing Disorders; Hearing Tests; Humans; Infant; Infant, Newborn; Male; Middle Aged; Streptomycin; Time Factors; Tuberculosis, Pulmonary; Vertigo | 1972 |